Skip to main content
OpenTrials
Completed

NCT Number: NCT01811264

Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer

Through a patient participation aid (PPA) the investigators hope to improve the psychosocial well-being of women diagnosed with metastatic breast cancer by empowering them to be active participants in clinical encounters.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

H Lee Moffitt Comprehensive Cancer Center, Tampa, Florida, United States

Loading trial locations.

About this study

The team has developed a brief Patient Participation Aid (PPA) to promote patient health literacy and encourage women to be active in the decisions that are being made about their healthcare which will lead to their satisfaction with healthcare and improves their psychosocial well-being. The paper-based PPA uses adult learning principles to limit and sequence plain language messages that have been framed from a patient's perspective. The PPA uses theory-based design to increase patients' involvement in the medical visit by modeling - through text and images - how a patient can: 1) set the visit agenda, 2) formulate questions, and 3) assert personal preferences. The specific aims of this study are to: 1- Assess the effectiveness of the PPA to increase patient involvement during clinical encounters. 2- Evaluate the effectiveness of the PPA to improve patient psychosocial outcomes. 3- Explore if the effect of the PPA varies by patients' literacy skills. To achieve this aims, the investigators will conduct a randomized controlled trial to evaluate the PPA among patients with a new diagnosis or progression of metastatic breast cancer at two cancer centers that serve diverse patient populations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • female patients with metastatic breast cancer seeing one of the study physicians at one of the identified study clinics
  • age 21 or older
  • having suspected progression of metastatic disease

Exclusion criteria

  • patients with an uncorrectable hearing impairment or having limited English proficiency, as this would adversely affect their ability to communicate with the physician
  • patients with uncorrectable vision impairment, as this would make it impractical for the patient to read the intervention
  • patients too ill to meaningfully converse with the physician

Treatment and study plan

Patient-Participation Aid

Behavioral

The PPA consists of a folder that addresses the three behaviors we hope to influence: agenda setting, asking questions, and making preferences known. The information inside contains sample questions for each section, with room for the patient to write her own questions. Each section models behavior by giving context for the items and specific example questions. It also addresses barriers to understanding by indicating that it is acceptable to ask questions when something is not clear or terms are unfamiliar.

Other names: PPA

Primary outcomes

  1. Functional Assessment of Cancer Therapy - General (FACT-G)

    Time frame: Change in functional assessment of cancer therapy from pre-visit at 3 months post-visit

    Evaluated at 30 minutes prior to, one week after, and 3 months after the patients visit with their doctor, this measure collects scales of the social and family well-being, emotional well-being, and functional well-being.

Secondary outcomes

  1. Rapid Estimate of Adult Literacy in Medicine (REALM-SF)

    Time frame: Pre-Visit

    A 7-item word recognition test to provide clinicians with a valid quick assessment of patient health literacy.

Other outcomes

  1. Decision Regret Scale

    Time frame: Change in decision regret from pre-visit at 3 months post-visit

    Collected at post-visit, and follow-ups, this measures the patient's regret and feelings regarding the most recent treatment-related decision

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Collaborators

  • American Cancer Society, Inc.

Registry information

Important dates

Study start
2013
Primary completion
2017
Study completion
2017
First posted
Mar 14, 2013
Registry last updated
Jul 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.